KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Inventory (2016 - 2025)

West Pharmaceutical Services' Inventory history spans 17 years, with the latest figure at $443.9 million for Q4 2025.

  • For Q4 2025, Inventory rose 17.75% year-over-year to $443.9 million; the TTM value through Dec 2025 reached $443.9 million, up 17.75%, while the annual FY2025 figure was $443.9 million, 17.75% up from the prior year.
  • Inventory for Q4 2025 was $443.9 million at West Pharmaceutical Services, up from $438.0 million in the prior quarter.
  • Across five years, Inventory topped out at $449.4 million in Q2 2023 and bottomed at $310.2 million in Q1 2021.
  • The 5-year median for Inventory is $415.6 million (2022), against an average of $406.3 million.
  • The largest annual shift saw Inventory soared 34.27% in 2022 before it dropped 13.27% in 2024.
  • A 5-year view of Inventory shows it stood at $378.4 million in 2021, then grew by 9.62% to $414.8 million in 2022, then grew by 4.8% to $434.7 million in 2023, then dropped by 13.27% to $377.0 million in 2024, then grew by 17.75% to $443.9 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Inventory are $443.9 million (Q4 2025), $438.0 million (Q3 2025), and $421.1 million (Q2 2025).